Microbiome: Emerging Opportunities for 2030 | June 10
Emerging Microbiome Treatments and Commercial Opportunities for 2030
What causes some people to develop chronic diseases such as rheumatoid arthritis, cancer, and metabolic syndrome while others stay healthy? A major clue could be found in their gut microbiome — the trillions of microbes living inside the digestive system that regulate various bodily functions.
Join us Thursday, June 10 at 11:00 am EDT for a live webinar on the latest research and outlook on microbiome approaches to the treatment of cancer and other diseases.
A panel of experts from the Mayo Clinic Center for Individualized Medicine, Mayo Clinic Ventures, and the Seerave Foundation will discuss innovations in microbiome that will impact care and where industry and startups have the most opportunity to commercialize advances in microbiome.
Olayemi (Yemi) Sokumbi, M.D., Associate Medical Director, Department of Business Development, Mayo Clinic in Florida
- Nicholas Chia, Ph.D., Associate Director, Mayo Clinic Center for Individualized Medicine Microbiome Program
- Purna C. Kashyap, M.B.B.S., Associate Director, Mayo Clinic Center for Individualized Medicine Microbiome Program
- Kelly Krajnik, Senior Director, Business Development, Mayo Clinic Ventures
- Manuel Fankhauser, Ph.D., Chief Scientific Officer, Seerave Foundation
This event is open to members, Mayo Clinic employees, and all friends of the Exchange. Register in advance to attend via Zoom.